ERYTECH Pharma announces the oral presentation of very demonstrative results regarding its technology to Induce specific immune tolerance by antigen loaded erythrocytes. Post author:admERY Post published:September 7, 2012 Post category:Newsroom You Might Also Like ERYTECH to Participate in the Upcoming April Investor Conferences March 28, 2022 ERYTECH Secures €10 Million in Non-Dilutive Financing, Guaranteed by the French Government November 2, 2020 ERYTECH reports financial highlights for Q3 2015 November 3, 2015
ERYTECH Secures €10 Million in Non-Dilutive Financing, Guaranteed by the French Government November 2, 2020